Review Article
Efficacy of Xuebijing Injection for Acute Pancreatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Table 5
Meta-analyses of AP-related complications.
| Endpoints | No. of studies | Pooled proportion using random-effects model | Heterogeneity | RR | | I2 (%) | |
| MODS | 4 | 0.18 (95% CI = 0.05 to 0.62) | 0.006 | 0 | 0.94 | ARDS | 3 | 0.38 (95% CI = 0.14 to 1.04) | 0.06 | 0 | 0.55 | Septicemia | 3 | 0.67 (95% CI = 0.19 to 2.36) | 0.54 | 0 | 0.54 | Pancreatic pseudocyst | 3 | 0.17 (95% CI = 0.04 to 0.77) | 0.02 | 0 | 0.80 | Shock | 2 | 0.30 (95% CI = 0.08 to 1.12) | 0.07 | 23 | 0.25 | Renal failure | 2 | 0.16 (95% CI = 0.05 to 0.60) | 0.006 | 0 | 0.55 | Pleural effusion or ascites | 2 | 0.35 (95% CI = 0.12 to 1.01) | 0.05 | 6 | 0.30 |
|
|
Abbreviations: AP: acute pancreatitis; RR: risk ratio; CI: confidence Interval; MODS: multiple organ dysfunction syndrome; ARDS: acute respiratory distress syndrome.
|